Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma
Clinical trial NCT04887025 · UNKNOWN
Trial details
- NCT number
- NCT04887025
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2023-03-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.